None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (= 18 years old) diagnosed with histologically confirmed solid malignancies (breast cancer, colorectal cancer) Patients scheduled to receive at least 3 months of systemic chemotherapy ECOG performance status 0-2
Exclusion criteria
Exclusion criteria: Severe psychiatric disorders Cognitive impairment affecting ability to report symptoms Presence of cancer-related symptoms prior to chemotherapy initiation Concurrent participation in trials evaluating other symptom management interventions Inability to provide informed consent Life expectancy less than 6 months
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with =8 points improvement in EORTC QLQ-C30 global health status/QoL scale;Frequency of grade 3-4 toxicities according to CTCAE v5.0 | — |
Primary
| Measure | Time frame |
|---|---|
| Change in health-related quality of life measured by EORTC QLQ-C30 global health status/QoL scale | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Incheon St. Mary's Hospital